Siddharth Mittal
Siddharth Mittal is the CEO of Biocon, a leading biopharmaceutical company in India. Under his leadership, Biocon is preparing to launch injectable weight-loss products, including semaglutide, in 2027, with plans for international exports to countries like Brazil and Canada.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Siddharth Mittal is the CEO of Biocon, which is investing in an injectables facility in Bengaluru.
7